Session » Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes - Poster I: Basic Science Focus

Date: Sunday, November 13, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 44

Ambroxol for Fibromyalgia. One-Group Pretest-Posttest Open Label Clinical Observation

9:00AM-11:00AM: Abstract Number: 37

Association Between Fibromyalgia and Bone Mineral Density: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 43

Comorbid Development of Fibromyalgia and Posttraumatic Stress Disorder after Exposure to a Combat Environment

9:00AM-11:00AM: Abstract Number: 32

Comparison of Effects of Leukocyte-RICH and Leukocyte-Poor Platelet-RICH Plasma on PAIN and Functionality in Patients with Lateral Epicondylitis

9:00AM-11:00AM: Abstract Number: 34

Differential Analgesic Pharmacological Effects on Brain Connectivity in Fibromyalgia (FM)

9:00AM-11:00AM: Abstract Number: 36

Dysautonomia and Osteoporosis in 2300 Ehlers-Danlos Hypermobile Patients, As Defined By the Brighton Criteria

9:00AM-11:00AM: Abstract Number: 39

Effects of Pregabalin (Lyrica®) on Cerebrospinal Fluid Substance P in Human Subjects with Fibromyalgia Syndrome

9:00AM-11:00AM: Abstract Number: 53

Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric Observational Study

9:00AM-11:00AM: Abstract Number: 49

Efficacy of Mirogabalin on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase 2 Proof-of-Concept Study

9:00AM-11:00AM: Abstract Number: 48

Fibromyalgia Impact Is a Potential Mediator for the Associations of Self-Efficacy and Pain Catastrophizing with Physical Functioning in Persons with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 38

How Does Thiol/Disulphide Homeostasis Change in Fibromyalgia Patients?

9:00AM-11:00AM: Abstract Number: 41

Human Papilloma Virus Vaccination, Fibromyalgia and Dysautonomia

9:00AM-11:00AM: Abstract Number: 40

Lateral Epicondylitis Treatment: Comparison of Bandage, Laser Therapy and Extra-Corporeal Shock Wave Therapy

9:00AM-11:00AM: Abstract Number: 46

Novel Composite Responder Endpoints for Fibromyalgia Therapy Assessment

9:00AM-11:00AM: Abstract Number: 54

Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research

9:00AM-11:00AM: Abstract Number: 52

Pregabalin Dose-Response for Sleep Quality and Pain Response in Fibromyalgia: A Post-Hoc Analysis of Three Randomized Trials

9:00AM-11:00AM: Abstract Number: 33

Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 42

Small Fibre Neuropathy Biopsies (SFN) in Primary Fibromyalgia Revealed Predominant Association with Metabolic Syndrome (in addition to other known treatable causes of SFN) but No Clear Distinction Related to Biopsy Results

9:00AM-11:00AM: Abstract Number: 45

Small Fiber Neuropathy in Rheumatology Clinics

9:00AM-11:00AM: Abstract Number: 50

Tai Chi Significantly Modulates Resting State Functional Connectivity of the Cognitive Control Network in Fibromyalgia

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].